We are interesting in investigating the different effects of neuroprotectants in animal disease model of optic neuropathies---the optic nerve crush model and rodent anterior ischemic optic neuropathy model. Our main goal is to study the pathophysiology of RGCs death in axon injury and to evaluate the neuroprotective mechanisms of potential therapeutic agents for optic neuropathies.

---